Bullish on Sun Pharma: Prabhudas Lilladher

  • 11:06
  • Published On: September 29, 2014
Cinema View
Embed
Ranbaxy's portfolio, along with that of Taro and Dusa Pharmaceuticals, will help Sun Pharma strengthen its franchise in dermatology, said Surjit Pal of Prabhudas Lilladher.

Related Videos

Sun Pharma Q4 Profit In Line With Estimates
May 26, 2023 0:35
Drug Major Sun Pharma Hit By Ransomware Attack
March 27, 2023 1:53
Nifty Hits 11,600, Sensex Opens Above 38,400 For First Time
August 23, 2018 0:41
Sensex, Nifty Open On A Flat Note
July 05, 2017 1:45
Sensex Opens On Weak Note, Sun Pharma Shares Outperform
June 30, 2017 3:14
Regulatory Environment Unfavourable For Pharma Companies: Surjit Pal
May 23, 2017 9:10
Q4 Review Of NBFCs
April 26, 2017 12:31
Positive On D-Mart For Long Term: Amnish Aggarwal
March 22, 2017 11:32
Ace Women Investors Devina Mehra & Amisha Vora Share Investment Mantras
March 08, 2017 22:31
Nifty Likely To Remain Firm, May Rally Further: R Sreesankar
March 02, 2017 15:07
Accumulate Bank of Baroda: R Sreesankar
February 13, 2017 10:36
RIL, Bank Of Baroda, SBI Among Top Picks: Niraj Dalal
February 08, 2017 34:50
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination